Related Posts
- IDO/PD-L1 Vaccine And Nivolumab Prove Effective For Metastatic Melanoma Patients
KEY TAKEAWAYS The phase I/II clinical trial studied the long-term follow-up data and a sub-group…
- TIL-Based Combination Therapy in Metastatic Melanoma
KEY TAKEAWAYS The TUNINTIL study phase 3 trial aimed to investigate the enhanced efficacy and…
- Nivolumab/Ipilimumab Plus Cabozantinib for Unresectable Melanoma
KEY TAKEAWAYS The phase II trial aimed to investigate the efficacy of nivo/ipi plus cabozantinib…